Avgemsi
Payments companies reported to CMS as associated with Avgemsi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Avgemsi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Avgemsi
These are the largest totals companies reported as associated with Avgemsi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Edward Licitra | East Brunswick, NJ | Medical Oncology | $366.62 |
| Salman Waheed | Joliet, IL | Hematology & Oncology | $269.52 |
| Shalin Shah | Plainfield, IL | Internal Medicine | $269.52 |
| Ranjana Chauhan | Hinsdale, IL | Ophthalmology | $269.52 |
| Samir Desai | Plainfield, IL | Hematology & Oncology | $269.52 |
| Aditi Sanatinia | Las Vegas, NV | Obstetrics & Gynecology | $185.32 |
| Hamidreza Sanatinia | Las Vegas, NV | Hematology & Oncology | $185.32 |
| Josy Mathew | Concord, NH | Hematology & Oncology | $167.30 |
| Kavita Kalra | Baltimore, MD | Hematology & Oncology | $167.30 |
| Carl Minniti | Mickleton, NJ | Hematology & Oncology | $167.30 |
Prescribed Avgemsi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.